Prenatal maternal psychological distress increases risk for adverse infant outcomes.
and salivary cortisol samples were collected diurnally and in response to a stressor.
Buccal swabs for DNA extraction and DNA methylation analysis were collected from each infant at two months of age, and mothers were assessed for postnatal depressive symptoms. Prenatal depressive symptoms significantly predicted increased NR3C1 1F DNA methylation in male infants ‫ﺲ(‬ = 2.147, P = 0.044). Prenatal depressive symptoms also significantly predicted decreased BDNF IV DNA methylation in both male and female infants ‫ﺲ(‬ = -3.244, P = 0.013). No measure of maternal cortisol during pregnancy predicted infant NR3C1 1F or BDNF promoter IV DNA methylation. Our findings highlight the susceptibility of males to changes in NR3C1 DNA methylation and present novel evidence for altered BDNF IV DNA methylation in response to maternal depression during pregnancy. The lack of association between maternal cortisol and infant DNA methylation suggests that effects of maternal depression may not be mediated directly by glucocorticoids. Future studies should consider other potential mediating mechanisms in the link between maternal mood and infant outcomes. 
Introduction
Psychological wellbeing during pregnancy can have long-term implications for offspring mental and physical health [1] [2] [3] [4] . In particular, psychological distress, which encompasses feelings of anxiety, depression, and perceived stress, increases risk for a number of adverse offspring outcomes [5] [6] [7] [8] [9] , including premature birth 10 , behavioral difficulties in childhood 5 , and psychiatric disorder in adulthood 7, 11 . However, the mechanism(s) that account for associations between prenatal distress and health outcomes are unclear.
The prevailing mechanistic theory in perinatal psychiatry to account for moodassociated effects in offspring is via alterations of the maternal hypothalamicpituitary-adrenal (HPA) axis during pregnancy 1, 4 . Indeed, symptoms of prenatal depression have been associated with increased diurnal salivary cortisol 12 , and exaggerated cortisol responses to an acute stressor 13 . Moreover, enduring changes in fetal DNA methylation have been proposed to be involved in entraining the fetal HPA axis in response to maternal distress 4, 14 . Epigenetic variation, including DNA methylation changes in brain regions involved in the regulation of HPA activity, have been observed in animal studies following prenatal exposure to stress 15 , maternal separation 16 , and in response to variation in mother-infant interactions 17, 18 , with implications for the HPA response to stress. In particular, increased DNA methylation in the promoter region of the gene encoding the glucocorticoid receptor (Nr3c1) in the hippocampus has been observed, and may account for heightened glucocorticoid levels in offspring 19 .
The glucocorticoid receptor (GR) plays a critical role in HPA responses to stress through negative feedback on glucocorticoid release. Increased DNA methylation within the Nr3c1 gene results in decreased expression of hippocampal GR, a dampening of negative feedback, and prolonged increase in circulating glucocorticoid levels 19 . In rodents, offspring that experience low compared to high levels of postnatal maternal care have increased hippocampal Nr3c1 DNA methylation and reduced Nr3c1 expression. Cross-fostering studies have confirmed that these epigenetic changes emerge in response to maternal care during the postnatal period, and pharmacological studies have indicated that shifts in hippocampal Nr3c1 DNA methylation can modulate the behavioral and physiological response to stress 20 .
Although the epigenetic effects of maternal care are not restricted to Nr3c1 21, 22 , this target gene may be particularly relevant to understanding the coordinated biological response observed following exposure to early life adversity.
Translational studies examining the association between exposure to early life stress and NR3C1 exon 1F DNA methylation in humans have generated findings consistent with animal studies using both post-mortem brain samples and peripheral tissues [23] [24] [25] .
Increased NR3C1 exon 1F methylation and decreased GR mRNA have been detected in the hippocampus of suicide victims with a history of childhood abuse 23 . Increased NR3C1 1F DNA methylation has also been detected in DNA extracted from whole blood samples from young adolescents exposed to physical abuse in childhood 24 , and adolescents exposed to stressful life events or trauma 25 . This susceptibility to alterations in NR3C1 DNA methylation is also observed in response to prenatal distress. Increased NR3C1 1F DNA methylation has been found in cord blood of infants exposed to maternal depressed mood during pregnancy and this altered epigenetic state was predictive of stress responses in these infants at three months of age 26 . Increased NR3C1 1F DNA methylation has also been observed in whole blood of young adolescents whose mothers had experienced intimate partner violence during pregnancy 27 .
Although gene targets associated with the HPA response to stress have predominated epigenetic studies of the impact of early life adversity, the complex behavioral phenotypes that emerge suggest the importance of genes involved in brain development and neuroplasticity, such as brain derived neurotrophic factor (BDNF).
BDNF plays an essential role in neurodevelopment and has been linked to psychiatric risk 28 . In animal studies, maternal stress during pregnancy induces increased bdnf promoter IV DNA methylation and decreased BDNF expression in the amygdala and hippocampus in offspring that persist into adulthood 29 . Persistent epigenetic changes in bdnf, within the cortex of offspring, are also observed in response to abusive caregiving during the postnatal period [29] [30] [31] [32] . We have recently found that increased BDNF promoter IV DNA methylation in peripheral blood may be a significant biomarker of prenatal adversity that is relevant for both animals and humans 33 .
However, the impact of prenatal psychological distress on infant BDNF IV DNA methylation has yet to be explored. 
Results

Sample characteristics
The demographic characteristics of this sample are presented in 
P<0.05).
Examples of reported delivery complications include the development of preeclampsia resulting in an induced birth, signs of fetal distress leading to an assisted delivery, and a retained placenta. There were no significant differences between women who did and did not report delivery complications on measures of prenatal cortisol or postnatal depression.
Maternal prenatal depressive symptoms and infant NR3C1 1F and BDNF IV DNA methylation
None of the maternal demographic variables, including prenatal depression, significantly correlated with DNA methylation at any CpG site. In the regression analyses, mean DNA methylation of all 10 CpG sites within NR3C1 1F was first used as the outcome variable. There was a significant effect of the prenatal depression*gender interaction to predict mean NR3C1 1F DNA methylation ‫ﺲ(‬ =-0.350, P=0.017); see Table 2 . To investigate this interaction further, the data was split Table 2 . This model was reconstructed using % DNA methylation at each CpG site as the outcome variable.
Prenatal depression significantly predicted % DNA methylation at CpG3 only ‫-=ﺲ(‬ 3.244, P=0.002), such that those infants exposed to antenatal depression had decreased methylation at CpG3. These results are presented graphically in Figure 2 .
Maternal prenatal cortisol and infant NR3C1 1F and BDNF IV DNA methylation
Two measures of maternal cortisol were available: mean change in response to a stressor and the log AUC for diurnal cortisol. Regression models were constructed as previously described, but each measure of maternal cortisol was used in the place of prenatal depression, and days-of-gestation was entered as a covariate. 
Discussion
Maternal depression is predictive of adverse psychiatric and physical outcomes in offspring [7] [8] [9] [10] and it has been speculated that elevated maternal glucocorticoids may induce these effects 1, 4, 14 . Moreover, there is increasing evidence for the role of epigenetic variation in the lasting consequences of early life adversity 19, 22, 23, 26 . In the current study, we find a sex-specific effect of maternal prenatal depressive symptoms on DNA methylation within the NR3C1 gene, with elevated NR3C1 1F DNA methylation in male, but not female, infants exposed to maternal prenatal depression. Analysis of the BDNF promoter IV region revealed that both male and female infants exposed to prenatal depression had decreased DNA BDNF IV methylation. However, for both NR3C1 and BDNF, maternal cortisol did not predict infant DNA methylation changes.
Variation in DNA methylation within the NR3C1 1F region has been reported in both animal 15, 18, 19 and human [23] [24] [25] [26] [27] studies, suggesting that this epigenetic marker is developmentally sensitive to the quality of the environment. These studies have consistently reported increased DNA methylation of NR3C1 1F and our findings DNA methylation [23] [24] [25] [26] [27] , and although animal studies have primarily examined these effects exclusively in males, there is emerging evidence suggestive of a particular epigenetic vulnerability in males in response to prenatal 33 and postnatal 35 experiences. These findings compliment a body of literature, which suggests that males may more be at risk of adverse outcomes compared to females as a result of exposure to maternal distress during pregnancy [36] [37] [38] [39] [40] . Therefore, sex differences in NR3C1 DNA methylation could, in part, explain stronger associations between prenatal mood disturbance and more adverse outcomes in males. Importantly, the differentially methylated region of NR3C1 contains the binding site for the transcription factor NGFI-A (Figure 1 ; CpG sites 8 and 9) and is directly involved in the DNA methylation-mediated regulation of NR3C1 expression 23 . Although it is unlikely that DNA methylation differences occurring at a single gene could account for the increased risk for complex outcomes in later life, our findings suggest that epigenetic disruption at this locus may be functionally relevant to the impact of maternal depression on offspring development.
Previous studies in animals have suggested that increased bdnf IV DNA methylation emerges as a consequence of elevated prenatal stress 29 and Bisphenol A (BPA) exposure 16 . In contrast, we report that in human infants, exposure to prenatal depression results in decreased infant BDNF IV methylation at CpG3. This CpG site is adjacent to the binding site of the transcription factor CREB (Figure 1 ), which controls BDNF transcription via DNA methylation-dependent mechanism 41 .
Although species differences in the regulation of this gene may account for our findings, recent analyses indicate increased DNA methylation in human cord blood samples within the CREB binding site associated with elevated in utero BPA exposure, which is consistent with the direction of reported effects in rodents 42 . An alternative explanation for these findings may involve the biphasic epigenetic changes that have been observed to occur across development 43 .
The decreased BDNF methylation we observe in infants exposed to prenatal depression could reflect a molecular basis for the rapid maturation that may be induced by adverse prenatal events. BDNF is a critical growth factor involved in neurogenesis, and so the timing of regulation and expression of BDNF serves as a marker of developmental time. Stress during pregnancy induces an increased risk of preterm delivery 44 and may lead to an advanced pace of neurodevelopment [45] [46] [47] .
Consistent with this, children who have experienced maternal deprivation in early life have been shown to have mature connectivity between the amygdala and medial prefrontal cortex that is comparable to an adolescent phenotype 48 , suggestive of more rapid brain development. Further exploration of this hypothesis from both a molecular and neurodevelopmental level may provide insights into the mechanisms that underlie adversity-induced changes in brain maturation. suggested that biological markers of prenatal stress may be better indicators of offspring outcomes than self-report measures 34 . Thus, we expected that maternal cortisol would significantly predict infant NR3C1 IF and BDNF IV methylation.
However, we found no evidence to support this hypothesis. Moreover, in our cohort, maternal depressive symptoms were not correlated with elevated diurnal or stressinduced glucocorticoid levels. The lack of group differences in glucocorticoid levels and the relatively low variability of cortisol levels between individuals may account for this finding. However, this initial investigation suggests that perhaps maternal cortisol does not account for the association between prenatal depression and changes in infant DNA methylation, and future studies should consider other potential mediating pathways, such as changes in maternal immune activation.
The prospective longitudinal design and the inclusion of both biological and psychological measures of maternal prenatal distress as predictors of infant methylation are significant strengths of this study. This is also the first study to replicate the previous finding of increased NR3C1 DNA methylation in response to maternal depression 26 
Methods and Materials
Participants
The participants (N=57) were derived from a larger cohort of pregnant women participating in a longitudinal study based in Oxford, UK. This study was designed to 
Procedures
Participants were assessed during either the second or third trimester of pregnancy.
Self-reported symptoms of depression were obtained using a paper-based questionnaire (Edinburgh Postnatal Depression Scale) and maternal salivary cortisol samples were collected in two contexts: in response to a stressor (infant distress video) and diurnally. Participants were visited at home approximately 2 months after birth. Self-report measures of postnatal depression from the mother and two buccal swabs from each infant were collected. 
Measures
Maternal mood Edinburgh Postnatal Depression Scale (EPDS).
The EPDS is the most widely used self-report questionnaire to identify symptoms of depression during the peripartum period. The scale consists of 10 items that describe common symptom of depression;
however, it does not include somatic symptoms of depression, such as change in appetite, which are commonly experienced in pregnancy. Each item is scored from 0 to 3, with a maximum score of 30. A cut-off score of 10 is frequently used to identify a group at risk of depression [59] [60] [61] [62] [63] . A recent study has shown that using a cut-off of 10 in the second and third trimester of pregnancy provides a good balance between sensitivity (70-79%) and specificity (96-97%) 63 .
Maternal prenatal cortisol
Response to infant distress stimulus. During either the second or third trimester, participants were invited to an afternoon test session between the hours of 2 P.M. and 7 P.M., and asked to watch a short film depicting distressed young infants, all under the age of 6 months. The film was 6 minutes in length and included 8 short clips of crying infants. The clips were taken from online sources with permission from the owners. This video has been used in a previous study 13 was used as a main predictor in these analyses. This variable was calculated by subtracting the mean baseline cortisol measure from the 20-minute post-stimulus measure. Notably, there were no differences between the control and depressivesymptom group in baseline cortisol.
Diurnal cortisol. Participants were asked to collect six saliva samples at home over two working days (three per day) within two weeks of the test session. On each day samples were collected immediately after awakening, 30 minutes and 12 hours postawakening. Participants were provided with a stamped addressed envelope to return the samples, which were stored at -20°C until analysis. The area under the curve of the diurnal cortisol data was skewed to the left, and was therefore log transformed (log AUC), and log AUC was used as a main predictor in this study.
Cortisol assay
Salivary cortisol analysis was carried out by a direct double-antibody radioimmunoassay (RIA) with utilization of 125I-cortisol as the ligand, in accordance with the manufacturer s instructions (Salimetrics Inc., UK).
Infant NR3C1 1F and BDNF IV methylation
Buccal swab collection
Infants were on average 53.6 days old (SD=9.99, range=26-98 days) when the buccal swabs were collected. The buccal swabs were obtained using Catch-All soft sample swabs (Epicentre Ltd), which were firmly bushed across the inside of the infant s cheek, and stored in sterilized 2 ml tubes. Samples were stored at - Psychology at Columbia University on dry ice (World Courier Ltd), where they were stored at -80 o C until analysis.
DNA isolation
Buccal cell DNA isolation was performed using a QIAamp DNA mini kit (Qiagen Ltd, USA) in accordance with the manufacturer s protocol, and the buccal DNA was quantified using a Nanodrop 1000 spectrophotometer (Thermo Scientific Ltd, USA).
The extracted DNA was in a range of 6-31 ng/‫ﺼ‬ l.
Bisulfite pyrosequencing
DNA methylation at specific CpG sites was analyzed using the quantitative bisulfitepyrosequencing method. The extracted buccal DNA (125ng) was bisulfite converted using an EpiTect Bisulphite kit (Qiagen Ltd, USA) according to the manufacturer s instructions, and stored at -20 o C until further analysis. A PyroMark PCR kit (Qiagen Ltd, USA) and PCR primers specific for NR3C1 and BDNF were used to obtain biotinylated PCR products and a specific sequencing primer was then used to determine CpG methylation in the regions of interest. Two separate assays were used to assess 10 CpG sites within NR3C1 exon 1F, and one assay was used to assess 5
CpG sites within BDNF promoter IV (Figure 3) . Details of the primers used are available in Table 3 . The PCR and pyrosequencing primers were designed using PyroMark Assay Design Software 2.0. The regions of interest within NR3C1 and BDNF were chosen based on previous research that has identified these areas as susceptible to epigenetic regulation following early exposure to adverse environmental influences 23, 26, 28, 33 . Pyrosequencing was performed using a PyroMark Q24 pyrosequencer (Qiagen Ltd, USA) with specific pyrosequencing primers. Before 
Statistical analysis
For analysis, participants were split into two groups based on maternal EPDS score:
those scoring 9 or below were the control group, whereas those scoring 10 or above were the depressive symptom group. Independent samples t-tests and Pearson chisquared tests were used to determine group differences in demographic characteristics and maternal prenatal mood. Pearson s correlations were used to assess the relationship between variables and DNA methylation at independent CpG sites, and multiple regression models were constructed to examine predictive models. Data were entered into each model in a stepwise fashion: batch number for DNA methylation analysis was entered at step 1 as a covariate, as was postnatal depression. The postnatal depression group (control vs. depressive-symptoms) was defined using the same criteria as the prenatal depression group. Main predictor variables were entered at step 2. Either prenatal depression or maternal cortisol was used as a main predictor, as was infant gender. Where prenatal cortisol was a main predictor, days of gestation at the point of cortisol collection was entered as a covariate. Interaction variables between infant gender and prenatal depression or cortisol were created using standardized or centered variables, and entered into step 3 of the model.
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